Parametric Portfolio Associates LLC grew its position in shares of Cerner Co. (NASDAQ:CERN) by 14.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 632,386 shares of the company’s stock after purchasing an additional 77,541 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.19% of Cerner worth $45,102,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Cerner by 3.1% during the 2nd quarter. Vanguard Group Inc. now owns 29,296,545 shares of the company’s stock valued at $1,947,341,000 after acquiring an additional 876,919 shares during the period. BlackRock Inc. lifted its position in shares of Cerner by 0.8% during the 2nd quarter. BlackRock Inc. now owns 18,436,042 shares of the company’s stock valued at $1,225,441,000 after acquiring an additional 137,320 shares during the period. FMR LLC lifted its position in shares of Cerner by 0.8% during the 2nd quarter. FMR LLC now owns 5,652,931 shares of the company’s stock valued at $375,750,000 after acquiring an additional 43,521 shares during the period. Capital International Investors lifted its position in shares of Cerner by 0.3% during the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock valued at $345,994,000 after acquiring an additional 12,178 shares during the period. Finally, American Century Companies Inc. lifted its position in shares of Cerner by 62.4% during the 2nd quarter. American Century Companies Inc. now owns 3,929,394 shares of the company’s stock valued at $261,187,000 after acquiring an additional 1,510,288 shares during the period. 81.82% of the stock is currently owned by institutional investors.
Cerner Co. (NASDAQ CERN) traded up $0.26 during trading on Friday, hitting $72.90. 1,750,000 shares of the stock traded hands, compared to its average volume of 1,730,000. The company has a quick ratio of 2.75, a current ratio of 2.77 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $24,230.00, a PE ratio of 36.27, a PEG ratio of 2.11 and a beta of 0.94. Cerner Co. has a twelve month low of $50.13 and a twelve month high of $73.86.
Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Thursday, October 26th. The company reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.62 by ($0.01). The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. The company’s revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the business earned $0.59 earnings per share. equities research analysts forecast that Cerner Co. will post 2.24 earnings per share for the current year.
Several brokerages recently issued reports on CERN. Royal Bank of Canada restated a “buy” rating on shares of Cerner in a research report on Wednesday, October 25th. Jefferies Group reiterated a “buy” rating on shares of Cerner in a report on Sunday, October 29th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $70.00 price target on shares of Cerner in a research report on Thursday, November 30th. Citigroup initiated coverage on shares of Cerner in a research report on Thursday, January 4th. They set a “neutral” rating for the company. Finally, BidaskClub lowered shares of Cerner from a “buy” rating to a “hold” rating in a report on Friday, December 22nd. Fourteen investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Cerner has an average rating of “Hold” and a consensus target price of $69.83.
In related news, VP Michael R. Battaglioli sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total transaction of $279,560.00. Following the completion of the sale, the vice president now directly owns 4,000 shares in the company, valued at $279,560. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Clifford W. Illig sold 140,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $65.52, for a total transaction of $9,172,800.00. Following the sale, the chief executive officer now owns 1,229,719 shares of the company’s stock, valued at $80,571,188.88. The disclosure for this sale can be found here. Insiders sold 788,000 shares of company stock valued at $52,190,800 over the last quarter. Insiders own 13.11% of the company’s stock.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.